The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background & AimsCurrently, routine antiviral treatment is not recommended for immune‐tolerant subjects with chronic HBV infection. In this study, we assessed the treatment efficacy of combining Peg IFN α‐2a with Adefovir (CPIA) in chronic HBV infected pregnant women with normal levels of ALT and high levels of HBV after delivery.
MethodsChronic hepatitis B pregnant women with normal levels of...
BackgroundVirus‐specific T‐cell responses play a major role in antiviral immune response. However, the effect of hepatitis C virus (HCV)‐specific T‐cell responses on combination therapy still remains controversial.
AimsTo identify the association between HCV‐specific T cell responses and efficiency of combination therapy.
MethodsTo address this issue, a longitudinal analysis of HCV‐specific T‐cell...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.